BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 25521685)

  • 21. Impact of inducible co-stimulatory molecule (ICOS) on T-cell responses and protection against Mycobacterium tuberculosis infection.
    Nouailles G; Day TA; Kuhlmann S; Loewe D; Dorhoi A; Gamradt P; Hurwitz R; Jörg S; Pradl L; Hutloff A; Koch M; Kursar M; Kaufmann SH
    Eur J Immunol; 2011 Apr; 41(4):981-91. PubMed ID: 21337542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges and solutions for a rational vaccine design for TB-endemic regions.
    Gowthaman U; Mushtaq K; Tan AC; Rai PK; Jackson DC; Agrewala JN
    Crit Rev Microbiol; 2015; 41(3):389-98. PubMed ID: 24495096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Protective immunity against Mycobacterium tuberculosis].
    Kawamura I
    Kekkaku; 2010 Jun; 85(6):539-46. PubMed ID: 20662250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virulence-Dependent Alterations in the Kinetics of Immune Cells during Pulmonary Infection by Mycobacterium tuberculosis.
    Kim WS; Kim JS; Cha SB; Han SJ; Kim H; Kwon KW; Kim SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(12):e0145234. PubMed ID: 26675186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innate and acquired immune responses to mycobacterial infections: involvement of IL-17A/IL-23 axis in protective immunity.
    Umemura M; Matsuzaki G
    Nihon Hansenbyo Gakkai Zasshi; 2013 Dec; 82(3):123-32. PubMed ID: 24579460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Immunology of Tuberculosis.
    Scriba TJ; Coussens AK; Fletcher HA
    Microbiol Spectr; 2016 Aug; 4(4):. PubMed ID: 27726784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV Progression Perturbs the Balance of the Cell-Mediated and Anti-Inflammatory Adaptive and Innate Mycobacterial Immune Response.
    DiNardo AR; Mandalakas AM; Maphalala G; Mtetwa G; Mndzebele T; Ustero P; Hlatshwayo M; Mace EM; Orange JS; Makedonas G
    Mediators Inflamm; 2016; 2016():1478340. PubMed ID: 27006526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B cells and antibodies in the defense against Mycobacterium tuberculosis infection.
    Achkar JM; Chan J; Casadevall A
    Immunol Rev; 2015 Mar; 264(1):167-81. PubMed ID: 25703559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-gamma by CD4 T cells and participates in granuloma stability.
    Ordway D; Higgins DM; Sanchez-Campillo J; Spencer JS; Henao-Tamayo M; Harton M; Orme IM; Gonzalez Juarrero M
    J Leukoc Biol; 2007 Nov; 82(5):1221-9. PubMed ID: 17699612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recruitment of Mycobacterium tuberculosis specific CD4+ T cells to the site of infection for diagnosis of active tuberculosis.
    Nemeth J; Winkler HM; Zwick RH; Rumetshofer R; Schenk P; Burghuber OC; Graninger W; Ramharter M; Winkler S
    J Intern Med; 2009 Jan; 265(1):163-8. PubMed ID: 18793244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function.
    du Plessis N; Loebenberg L; Kriel M; von Groote-Bidlingmaier F; Ribechini E; Loxton AG; van Helden PD; Lutz MB; Walzl G
    Am J Respir Crit Care Med; 2013 Sep; 188(6):724-32. PubMed ID: 23885784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptor 1 variations influence susceptibility and immune response to Mycobacterium tuberculosis.
    Dittrich N; Berrocal-Almanza LC; Thada S; Goyal S; Slevogt H; Sumanlatha G; Hussain A; Sur S; Burkert S; Oh DY; Valluri V; Schumann RR; Conrad ML
    Tuberculosis (Edinb); 2015 May; 95(3):328-35. PubMed ID: 25857934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12.
    Li L; Jiang Y; Lao S; Yang B; Yu S; Zhang Y; Wu C
    PLoS One; 2016; 11(1):e0147356. PubMed ID: 26785168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemokines in tuberculosis: the good, the bad and the ugly.
    Monin L; Khader SA
    Semin Immunol; 2014 Dec; 26(6):552-8. PubMed ID: 25444549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stealth Strategies of
    Naeem MA; Ahmad W; Tyagi R; Akram Q; Younus M; Liu X
    Curr Issues Mol Biol; 2021; 41():597-616. PubMed ID: 33068079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycobacterial infection induces a specific human innate immune response.
    Blischak JD; Tailleux L; Mitrano A; Barreiro LB; Gilad Y
    Sci Rep; 2015 Nov; 5():16882. PubMed ID: 26586179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation.
    Woodworth JS; Aagaard CS; Hansen PR; Cassidy JP; Agger EM; Andersen P
    J Immunol; 2014 Apr; 192(7):3247-58. PubMed ID: 24574499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of IL-10 in immune regulation during M. tuberculosis infection.
    Redford PS; Murray PJ; O'Garra A
    Mucosal Immunol; 2011 May; 4(3):261-70. PubMed ID: 21451501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88.
    Fremond CM; Yeremeev V; Nicolle DM; Jacobs M; Quesniaux VF; Ryffel B
    J Clin Invest; 2004 Dec; 114(12):1790-9. PubMed ID: 15599404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunity to tuberculosis.
    North RJ; Jung YJ
    Annu Rev Immunol; 2004; 22():599-623. PubMed ID: 15032590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.